- Fenoprofen
- Fenoprofen calcium
- Fenoprofen sodium
- 537-47-3Hydrazinecarboxamide,N-phenyl-
- 537-49-5L-Tyrosine, N-methyl-
- 53749-61-42-11-Substance P
- 53750-66-62-Pyridinecarbonylchloride, 4-chloro-
- 537-55-3N-Acetyl-L-tyrosine
- 53755-76-3Lyclaninol
- 53755-77-41H-Cyclohepta[1,2-a:5,4-a']dinaphthalene-4- carboxylic acid,2,3,4,4a,5,6,6a,7,9,9a,10,11,12,- 13,13a,13b,14,15,15a,15b-eicosahydro-3,11- dihydroxy-4,6a,10,10,13a,15b-hexamethyl-,(3S,4R,4aR,6aS,9aR,11R,13aR,13bS,15aS,- 15bR)-
- 53758-26-2Tetradecanoicacid,2,3,3a,9a-tetrahydro-2-(hydroxymethyl)-6-imino-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-3-ylester, monohydrochloride, [2R-(2a,3b,3ab,9ab)]- (9CI)
- 53760-27-3N-(4-aminophenyl)benzene-1,4-diamine
- 5376-10-31H-Imidazole-2-methanol,1-(phenylmethyl)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Fenoprofen calcium |
EINECS | 252-107-9 |
| CAS No. | 53746-45-5 | Density | 1.17 |
| PSA | 89.52000 | LogP | 7.05120 |
| Solubility | N/A | Melting Point |
-40 °C |
| Formula | C30H26CaO6.2H2O | Boiling Point | 381.3 °C at 760 mmHg |
| Molecular Weight | 558.63 | Flash Point | 141.7 °C |
| Transport Information | N/A | Appearance | White powder |
| Safety | 36 | Risk Codes | 20/21/22 |
| Molecular Structure |
|
Hazard Symbols |
 Xn
|
| Synonyms |
(+-)-alpha-methyl-3-phenoxybenzeneaceticacidcalciumsaltdihydrate;calcium2-(m-phenoxyphenyl)propionatedihydrate; |
Fenoprofen calcium Specification
The Fenoprofen calcium with the cas registry number 53746-45-5, Its systematic name is Calcium 2-(3-phenoxyphenyl)propanoate . It also can be called as Benzeneacetic acid, alpha-methyl-3-phenoxy-, calcium salt (2:1) ; Bis[2-(3-phénoxyphényl)propanoate] de calcium ; 2-(3-Phenoxyphenyl)propionic acid calcium salt .
Properties of Fenoprofen calcium :(1)Enthalpy of Vaporization: 66.41 kJ/mol ; (2)Vapour Pressure: 1.71E-06 mmHg at 25 °C ; (3)H-Bond Donor: 2 ; (4)H-Bond Acceptor: 8 ; (5)Rotatable Bond Count: 6
You can still convert the following datas into molecular structure :
(1)SMILES: [Ca+2].[O-]C(=O)C(c2cc(Oc1ccccc1)ccc2)C.[O-]C(=O)C(c2cc(Oc1ccccc1)ccc2)C
(2)InChI: InChI=1/2C15H14O3.Ca/c2*1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13;/h2*2-11H,1H3,(H,16,17);/q;;+2/p-2
(3)InChIKey: VHUXSAWXWSTUOD-NUQVWONBAD
(4)Std. InChI: InChI=1S/2C15H14O3.Ca/c2*1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13;/h2*2-11H,1H3,(H,16,17);/q;;+2/p-2
(5)Std. InChIKey: VHUXSAWXWSTUOD-UHFFFAOYSA-L
Toxicity data of Fenoprofen calcium (CAS No.53746-45-5) is as following:
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source man TDLo oral 521mg/kg/17W- (521mg/kg) KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION
KIDNEY, URETER, AND BLADDER: OTHER CHANGESAnnals of Internal Medicine. Vol. 93, Pg. 508, 1980. mouse LD50 intraperitoneal 286mg/kg (286mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSIONYakkyoku. Pharmacy. Vol. 34, Pg. 363, 1983. mouse LD50 intravenous 471mg/kg (471mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSIONYakkyoku. Pharmacy. Vol. 34, Pg. 363, 1983. mouse LD50 oral 439mg/kg (439mg/kg) Yaoxue Tongbao. Bulletin of Pharmacology. Vol. 21, Pg. 36, 1986. mouse LD50 subcutaneous 463mg/kg (463mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSIONYakkyoku. Pharmacy. Vol. 34, Pg. 363, 1983. rat LD50 intraperitoneal 234mg/kg (234mg/kg) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE
GASTROINTESTINAL: OTHER CHANGES
BLOOD: NORMOCYTIC ANEMIAYakkyoku. Pharmacy. Vol. 34, Pg. 363, 1983. rat LD50 intravenous 526mg/kg (526mg/kg) GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE
BLOOD: NORMOCYTIC ANEMIA
GASTROINTESTINAL: OTHER CHANGESYakkyoku. Pharmacy. Vol. 34, Pg. 363, 1983. rat LD50 oral 415mg/kg (415mg/kg) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
SKIN AND APPENDAGES (SKIN): HAIR: OTHER
BLOOD: NORMOCYTIC ANEMIAKiso to Rinsho. Clinical Report. Vol. 14, Pg. 4385, 1980. rat LD50 subcutaneous 366mg/kg (366mg/kg) Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 13, Pg. 1128, 1982. women LDLo oral 8748mg/kg/35W (8748mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA
KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITISAmerican Journal of Medicine. Vol. 72, Pg. 81, 1982. women TDLo oral 720mg/kg/30D- (720mg/kg) KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" JAMA, Journal of the American Medical Association. Vol. 242, Pg. 1896, 1979. women TDLo oral 1898mg/kg/12W (1898mg/kg) KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"
KIDNEY, URETER, AND BLADDER: OTHER CHANGESAnnals of Internal Medicine. Vol. 92, Pg. 72, 1980. women TDLo oral 5832mg/kg/35W (5832mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING
KIDNEY, URETER, AND BLADDER: INTERSTITIAL NEPHRITISAmerican Journal of Medicine. Vol. 72, Pg. 81, 1982.
What can I do for you?
Get Best Price
